Published in Ultrasound Med Biol on February 13, 2013
Experimental demonstration of passive acoustic imaging in the human skull cavity using CT-based aberration corrections. Med Phys (2015) 0.82
Refraction correction in 3D transcranial ultrasound imaging. Ultrason Imaging (2014) 0.79
3-D transcranial ultrasound imaging with bilateral phase aberration correction of multiple isoplanatic patches: a pilot human study with microbubble contrast enhancement. Ultrasound Med Biol (2013) 0.75
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Calculation of pressure fields from arbitrarily shaped, apodized, and excited ultrasound transducers. IEEE Trans Ultrason Ferroelectr Freq Control (1992) 8.18
Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg (1982) 7.41
The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke (1988) 4.22
Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA (2006) 3.50
Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA (2000) 3.43
Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol (2012) 2.59
500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn Reson Med (2004) 2.13
Phase-aberration correction using signals from point reflectors and diffuse scatterers: basic principles. IEEE Trans Ultrason Ferroelectr Freq Control (1988) 1.90
Contrast-enhanced transcranial color-coded duplex sonography in ischemic cerebrovascular disease. Stroke (1997) 1.82
An FFT-based technique for translation, rotation, and scale-invariant image registration. IEEE Trans Image Process (1996) 1.77
Inadequate acoustical temporal bone window in patients with a transient ischemic attack or minor stroke: role of skull thickness and bone density. Ultrasound Med Biol (2008) 1.73
Effect of emitted power on waveform intensity in transcranial Doppler. Stroke (1990) 1.68
Rate of successful recording of blood flow signals in the middle cerebral artery using transcranial Doppler sonography. Stroke (1993) 1.63
Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke (2008) 1.58
Enhanced ultrasound transmission through the human skull using shear mode conversion. J Acoust Soc Am (2004) 1.56
Attenuation and size distribution measurements of Definity and manipulated Definity populations. Ultrasound Med Biol (2007) 1.41
A hemisphere array for non-invasive ultrasound brain therapy and surgery. Phys Med Biol (2000) 1.40
Is transcranial Doppler a worthwhile addition to screening tests for cerebrovascular disease? J Vasc Surg (1995) 1.39
Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol (2003) 1.37
Stroke incidence and survival in the beginning of the 21st century in southern Sweden: comparisons with the late 20th century and projections into the future. Stroke (2007) 1.29
Rationale and derivation of MI and TI--a review. Ultrasound Med Biol (1999) 1.26
Prehospital ultrasound in emergency medicine: incidence, feasibility, indications and diagnoses. Eur J Emerg Med (2010) 1.09
Clinical applications of focused ultrasound-the brain. Int J Hyperthermia (2007) 1.08
The acoustic characteristics of the skull. Ultrasound Med Biol (1978) 1.07
Insufficient and absent acoustic temporal bone window: potential and limitations of transcranial contrast-enhanced color-coded sonography and contrast-enhanced power-based sonography. Ultrasound Med Biol (1997) 1.05
On the suitability of broadband attenuation measurement for characterizing contrast microbubbles. Ultrasound Med Biol (2005) 1.04
Potential and limitations of transcranial color-coded sonography in stroke patients. Stroke (1995) 1.04
Characterization of ultrasound propagation through ex-vivo human temporal bone. Ultrasound Med Biol (2008) 1.03
Dual-frequency ultrasound imaging and therapeutic bilaminar array using frequency selective isolation layer. IEEE Trans Ultrason Ferroelectr Freq Control (2010) 1.03
Optimal focusing by spatio-temporal inverse filter. I. Basic principles. J Acoust Soc Am (2001) 1.03
Optimal focusing by spatio-temporal inverse filter. II. Experiments. Application to focusing through absorbing and reverberating media. J Acoust Soc Am (2001) 1.02
Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke (2001) 0.99
Transcranial ultrasound from diagnosis to early stroke treatment: part 2: prehospital neurosonography in patients with acute stroke: the Regensburg stroke mobile project. Cerebrovasc Dis (2012) 0.98
Time-shift compensation of ultrasonic pulse focus degradation using least-mean-square error estimates of arrival time. J Acoust Soc Am (1994) 0.98
Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography. J Ultrasound Med (2002) 0.98
Technical limits in transcranial Doppler recording: inadequate acoustic windows. Ultrasound Med Biol (1997) 0.95
Adaptive focusing for transcranial ultrasound imaging using dual arrays. J Acoust Soc Am (2006) 0.94
4.5 hours: the new time window for tissue plasminogen activator in stroke. Stroke (2009) 0.93
Evaluation of cerebrovascular disease by combined extracranial and transcranial Doppler sonography. Experience in 1,039 patients. Stroke (1988) 0.90
Real-time 3-D contrast-enhanced transcranial ultrasound and aberration correction. Ultrasound Med Biol (2008) 0.88
Comparison of transcranial color-coded sonography and magnetic resonance angiography in acute stroke. Stroke (1997) 0.88
Pitch-catch phase aberration correction of multiple isoplanatic patches for 3-D transcranial ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.86
Comparison of 3-D multi-lag cross- correlation and speckle brightness aberration correction algorithms on static and moving targets. IEEE Trans Ultrason Ferroelectr Freq Control (2009) 0.86
Transcranial ultrasound angiography (T USA): a new approach for contrast specific imaging of intracranial arteries. Ultrasound Med Biol (2005) 0.85
The ultrasound brain helmet: feasibility study of multiple simultaneous 3D scans of cerebral vasculature. Ultrasound Med Biol (2008) 0.84
Success rate of transcranial color-coded duplex ultrasonography in visualizing the basal cerebral arteries in vascular patients over 60 years of age. Stroke (1999) 0.84
[Assessment of the rate of successful transcranial Doppler recording through the temporal windows in Japanese with special reference to aging and sex]. Nihon Ronen Igakkai Zasshi (1992) 0.83
Transcranial shear-mode ultrasound: assessment of imaging performance and excitation techniques. IEEE Trans Med Imaging (2009) 0.83
Contrast-enhanced transcranial color-coded duplexsonography in stroke patients with limited bone windows. AJNR Am J Neuroradiol (2000) 0.83
The ultrasound brain helmet: new transducers and volume registration for in vivo simultaneous multi-transducer 3-D transcranial imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2011) 0.83
Stroke surveillance: population-based estimates and projections for New Zealand. Aust N Z J Public Health (2007) 0.82
Suitability of temporal bone acoustic window: conventional TCD versus transcranial color-coded duplex sonography. J Neuroimaging (2007) 0.82
Ultrasound safety with midfrequency transcranial sonothrombolysis: preliminary study on normal macaca monkey brain. Ultrasound Med Biol (2012) 0.82
Transcranial ultrasound from diagnosis to early stroke treatment. 1. Feasibility of prehospital cerebrovascular assessment. Cerebrovasc Dis (2008) 0.82
Diagnosis of intracerebral hemorrhage with transcranial ultrasound. Cerebrovasc Dis (2009) 0.81
Intracranial collateral pathways assessed by contrast-enhanced three-dimensional transcranial color-coded sonography. Ultrasound Med Biol (2004) 0.81
Stroke at high altitude diagnosed in the field using portable ultrasound. Wilderness Environ Med (2010) 0.81
A reason for failure to obtain transcranial Doppler flow signals. Hyperostosis of the skull. Stroke (1988) 0.80
Transcranial sonography in prehospital setting. Am J Emerg Med (2011) 0.79
A new 1-MHz probe for transcranial Doppler sonography in patients with inadequate temporal bone windows. Ultrasound Med Biol (1998) 0.79
Evaluation of a 1 MHz transducer for transcranial Doppler ultrasound including embolic signal detection. Ultrasound Med Biol (2001) 0.79
Visible improvement. Ultrasound provides diagnostic images in prehospital medicine. JEMS (2010) 0.78
Hyperostosis frontalis interna and hyperphosphatasemia. Ann Intern Med (1973) 0.76
Hyperostosis frontalis interna; two contrasting cases. J Am Med Assoc (1952) 0.76
Breast mass detection by US: a phantom study. Radiology (1985) 0.76
Transcranial Doppler ultrasonography and hyperostosis of the skull. Stroke (1988) 0.76
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90
Three deaths associated with use of Xyrem. Sleep Med (2009) 3.25
Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia*. Crit Care Med (2014) 2.73
Central nervous system injury associated with cardiac surgery. Lancet (2006) 2.27
Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke (2013) 2.05
Agitation is common in gamma-hydroxybutyrate toxicity. Am J Emerg Med (2005) 1.98
Wide complex tachycardia in a pediatric diphenhydramine overdose treated with sodium bicarbonate. Pediatr Emerg Care (2011) 1.96
Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med (2007) 1.89
Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-Balloon times across 10 independent regions. JACC Cardiovasc Interv (2009) 1.83
Novel diagnostic test for acute stroke. Stroke (2003) 1.82
APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem (2003) 1.80
APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med (2005) 1.70
Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury. Anesthesiology (2010) 1.68
Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med (2014) 1.60
A miniaturized catheter 2-D array for real-time, 3-D intracardiac echocardiography. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 1.60
Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke (2002) 1.57
Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem (2008) 1.55
Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med (2006) 1.51
Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay. Clin Biochem (2012) 1.49
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke (2005) 1.44
Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res (2002) 1.43
Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research. Ann Emerg Med (2008) 1.42
Early biomarkers of stroke. Clin Chem (2003) 1.41
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol (2005) 1.34
Preclinical models of intracerebral hemorrhage: a translational perspective. Neurocrit Care (2008) 1.29
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol (2007) 1.26
Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem (2009) 1.25
Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem (2008) 1.23
Vibrating interventional device detection using real-time 3-D color Doppler. IEEE Trans Ultrason Ferroelectr Freq Control (2008) 1.15
Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther (2006) 1.14
Real-time rectilinear 3-D ultrasound using receive mode multiplexing. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 1.11
A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care (2006) 1.09
Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases. Am J Surg Pathol (2003) 1.07
Two dimensional arrays for real time 3D intravascular ultrasound. Ultrason Imaging (2004) 1.07
Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. Stroke (2008) 1.07
Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med (2002) 1.06
Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg (2003) 1.05
The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg (2002) 1.05
Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol (2002) 1.05
Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma. Am J Emerg Med (2010) 1.04
3-D ultrasound guidance of surgical robotics: a feasibility study. IEEE Trans Ultrason Ferroelectr Freq Control (2006) 1.03
Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke (2009) 1.02
Autonomous surgical robotics using 3-D ultrasound guidance: feasibility study. Ultrason Imaging (2007) 1.02
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery (2002) 1.02
Piezoelectric vibrating needle and catheter for enhancing ultrasound-guided peripheral nerve blocks. Anesth Analg (2007) 1.02
Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation (2013) 1.01
S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. Biomarkers (2009) 1.00
Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery (2004) 1.00
Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans. J Stroke Cerebrovasc Dis (2009) 0.99
Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage. J Clin Neurosci (2012) 0.99
Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus (2006) 0.98
Depression and antidepressant use after stroke and transient ischemic attack. Stroke (2012) 0.97
Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. Circulation (2015) 0.96
Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg (2006) 0.95
New fabrication techniques for ring-array transducers for real-time 3D intravascular ultrasound. Ultrason Imaging (2009) 0.95
Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. Exp Neurol (2008) 0.94
Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J Neurotrauma (2010) 0.93
Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage. Neurocrit Care (2013) 0.93
Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care (2006) 0.92
Integrated catheter for 3-D intracardiac echocardiography and ultrasound ablation. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 0.92
Phase-aberration correction with a 3-D ultrasound scanner: feasibility study. IEEE Trans Ultrason Ferroelectr Freq Control (2006) 0.92
Bidirectional ventricular tachycardia resulting from herbal aconite poisoning. Ann Emerg Med (2005) 0.91
Dual-mode intracranial catheter integrating 3D ultrasound imaging and hyperthermia for neuro-oncology: feasibility study. Ultrason Imaging (2009) 0.90
Real-time rectilinear volumetric imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2002) 0.90
Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury. Neurosci Lett (2005) 0.90
Apolipoprotein E expression and behavioral toxicity of high charge, high energy (HZE) particle radiation. J Radiat Res (2002) 0.90
Evolving role of biomarkers in acute cerebrovascular disease. Ann Neurol (2012) 0.90
Analysis of a vibrating interventional device to improve 3-D colormark tracking. IEEE Trans Ultrason Ferroelectr Freq Control (2007) 0.90
3-D ultrasound guidance of autonomous robot for location of ferrous shrapnel. IEEE Trans Ultrason Ferroelectr Freq Control (2009) 0.89
Real-time 3D color flow Doppler for guidance of vibrating interventional devices. Ultrason Imaging (2004) 0.89
Real-time 3-D ultrasound guidance of interventional devices. IEEE Trans Ultrason Ferroelectr Freq Control (2008) 0.89
Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach. J Neurotrauma (2012) 0.89
Statins in traumatic brain injury. Neurotherapeutics (2010) 0.89
Real-time 3D laparoscopic ultrasonography. Ultrason Imaging (2005) 0.89
Real-time 3-D contrast-enhanced transcranial ultrasound and aberration correction. Ultrasound Med Biol (2008) 0.88
Real-time 3-d intracranial ultrasound with an endoscopic matrix array transducer. Ultrasound Med Biol (2007) 0.88
Clinical application of blood biomarkers in cerebrovascular disease. Expert Rev Neurother (2010) 0.87
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2010) 0.86
Relationship between blood alcohol concentration and observable symptoms of intoxication in patients presenting to an emergency department. Alcohol Alcohol (2013) 0.86
Pitch-catch phase aberration correction of multiple isoplanatic patches for 3-D transcranial ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.86
Comparison of 3-D multi-lag cross- correlation and speckle brightness aberration correction algorithms on static and moving targets. IEEE Trans Ultrason Ferroelectr Freq Control (2009) 0.86
Gender and age interact to affect early outcome after intracerebral hemorrhage. PLoS One (2013) 0.86
Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity. J Biol Chem (2012) 0.86
Dual-mode IVUS catheter for intracranial image-guided hyperthermia: feasibility study. IEEE Trans Ultrason Ferroelectr Freq Control (2010) 0.86
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke (2002) 0.86
TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice. Anesthesiology (2012) 0.85
Dual-mode IVUS transducer for image-guided brain therapy: preliminary experiments. Ultrasound Med Biol (2011) 0.85
Apolipoprotein E protects against NMDA excitotoxicity. Neurobiol Dis (2002) 0.85
Intracardiac catheter 2-D arrays on a silicon substrate. IEEE Trans Ultrason Ferroelectr Freq Control (2002) 0.84
Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. J Thorac Cardiovasc Surg (2003) 0.84
The ultrasound brain helmet: feasibility study of multiple simultaneous 3D scans of cerebral vasculature. Ultrasound Med Biol (2008) 0.84
ApolipoproteinE mimetic peptides improve outcome after focal ischemia. Exp Neurol (2012) 0.83
Effects of a manganese (III) porphyrin catalytic antioxidant in a mouse closed head injury model. Eur J Pharmacol (2006) 0.83